Literature DB >> 12412755

IgG anti-cardiolipin antibodies in murine lupus.

A E Gharavi1, R C Mellors, K B Elkon.   

Abstract

The frequency and nature of IgG anti-cardiolipin and anti-ds-DNA antibodies among MRL/lpr, MRL/+ and NZB/W F1 mice (murine lupus strains) and non-autoimmune inbred strains of mice (NIH/Swiss and Balb/c) were analysed by ELISA. High titres of anti-ds-DNA were detected in autoimmune strains (MRL/lpr, 69%; MRL/+, 50%; and NZB/W, 80% positive), whereas anti-cardiolipin antibodies were detected only in MRL/lpr (69%) and MRL/+ (17%) mice. IgG subclass analysis of these antibodies in 20 MRL/lpr sera revealed that all four subclasses were represented. When tested for fine antigenic specificity, anti-cardiolipin antibodies in MRL/lpr and MRL/+ mice bound to acidic phospholipids rather than to neutral phospholipids and were not inhibited by DNA. In MRL/lpr mice, anti-cardiolipin antibodies were first detected at 2 months, peaked around 5 months and then declined preterminally. To determine whether complications associated with anti-cardiolipin antibodies were present in MRL/lpr mice, blood counts were performed and litter sizes were determined. Although no significant decreases in the red and white blood cell counts were observed in MRL/lpr mice, platelet counts were significantly lower compared with NIH/Swiss (P < 0.001) and Balb/c (P < 0.005) mice. MRL/lpr mice had significantly fewer pups per delivery compared with a normal strain (MRL/lpr, 5.3+2.6; NIH/Swiss, 72 +/- 2.1; P < 0002). These observations indicate that the serological characteristics of IgG anti-cardiolipin antibodies in MRL/ lpr mice are similar to those of anti-cardiolipin antibodies in humans with lupus. Whether these autoantibodies are pathogenetically related to thrombocytopenia and a small litter size in MRL/lpr mice remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 12412755      PMCID: PMC1534669     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  26 in total

1.  Renal disease associated with positive lupus erythematosus tests in a cross-bred strain of mice.

Authors:  B J HELYER; J B HOWIE
Journal:  Nature       Date:  1963-01-12       Impact factor: 49.962

2.  Reaction patterns of monoclonal antibodies to DNA.

Authors:  R J Smeenk; K Brinkman; H G van den Brink; A A Westgeest
Journal:  J Immunol       Date:  1988-06-01       Impact factor: 5.422

3.  Ability of antigen-specific helper cells to effect a class-restricted increase in total Ig-secreting cells in spleens after immunization with the antigen.

Authors:  Y J Rosenberg; J M Chiller
Journal:  J Exp Med       Date:  1979-09-19       Impact factor: 14.307

4.  Polyspecific monoclonal lupus autoantibodies reactive with both polynucleotides and phospholipids.

Authors:  E M Lafer; J Rauch; C Andrzejewski; D Mudd; B Furie; B Furie; R S Schwartz; B D Stollar
Journal:  J Exp Med       Date:  1981-04-01       Impact factor: 14.307

5.  Autoimmune disease in NZB-Bl mice. II. Autoimmunity and malignant lymphoma.

Authors:  R C Mellors
Journal:  Blood       Date:  1966-04       Impact factor: 22.113

6.  Monoclonal hybridoma anti-cardiolipin antibodies from SLE mice.

Authors:  K Ichikawa; K Shimada; Y Nawata; T Ishii; H Tomioka; S Yoshida; T Koike
Journal:  Clin Exp Immunol       Date:  1988-10       Impact factor: 4.330

7.  Association between anti-Sm and anti-ribosomal P protein autoantibodies in human systemic lupus erythematosus and MRL/lpr mice.

Authors:  K B Elkon; E Bonfa; R Llovet; R A Eisenberg
Journal:  J Immunol       Date:  1989-09-01       Impact factor: 5.422

8.  Subclass restriction of murine anti-carbohydrate antibodies.

Authors:  R M Perlmutter; D Hansburg; D E Briles; R A Nicolotti; J M Davie
Journal:  J Immunol       Date:  1978-08       Impact factor: 5.422

9.  Wild-type Gross leukemia virus and the pathogenesis of the glomerulonephritis of New Zealand mice.

Authors:  R C Mellors; T Shirai; T Aoki; R J Huebner; K Krawczynski
Journal:  J Exp Med       Date:  1971-01-01       Impact factor: 14.307

10.  T cell regulation of IgG subclass antibody production in response to T-independent antigens.

Authors:  P K Mongini; K E Stein; W E Paul
Journal:  J Exp Med       Date:  1981-01-01       Impact factor: 14.307

View more
  17 in total

Review 1.  Antiphospholipid antibodies. A marker for thrombosis and recurrent abortion.

Authors:  M A Khamashta; G R Hughes
Journal:  Clin Rev Allergy       Date:  1994

2.  Relationship Between Fetal Loss and Serum Gonadal Hormones Level in Experimental Antiphospholipid Syndrome Mouse.

Authors:  Shanmugam Velayuthaprabhu; Arunachalam Chinnathambi; Sulaiman Ali Alharbi; Hidehiko Matsubayashi; Govindaraju Archunan
Journal:  Indian J Clin Biochem       Date:  2016-09-22

3.  Further characterization of the autoantibody response of Palmerston North mice.

Authors:  B S Handwerger; C E Storrer; C S Wasson; F Movafagh; M Reichlin
Journal:  J Clin Immunol       Date:  1999-01       Impact factor: 8.317

4.  Deficiency of fibroblast growth factor-inducible 14 (Fn14) preserves the filtration barrier and ameliorates lupus nephritis.

Authors:  Yumin Xia; Leal C Herlitz; Simona Gindea; Jing Wen; Rahul D Pawar; Alexander Misharin; Harris Perlman; Lan Wu; Ping Wu; Jennifer S Michaelson; Linda C Burkly; Chaim Putterman
Journal:  J Am Soc Nephrol       Date:  2014-09-30       Impact factor: 10.121

5.  Monoclonal anticardiolipin antibodies derived from mice with experimental lupus erythematosus: characterization and the induction of a secondary antiphospholipid syndrome.

Authors:  Z M Sthoeger; B Tartakovsky; Z Bentwich; E Mozes
Journal:  J Clin Immunol       Date:  1993-03       Impact factor: 8.317

6.  Activation of cultured vascular endothelial cells by antiphospholipid antibodies.

Authors:  R Simantov; J M LaSala; S K Lo; A E Gharavi; L R Sammaritano; J E Salmon; R L Silverstein
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

7.  Induction of antiphospholipid autoantibodies by immunization with beta 2 glycoprotein I (apolipoprotein H).

Authors:  A E Gharavi; L R Sammaritano; J Wen; K B Elkon
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

8.  Pathogenic natural anti-cardiolipin antibodies: the experience from monoclonal gammopathy.

Authors:  J Cohen; R Bakimer; M Blank; G Valesini; Y Shoenfeld
Journal:  Clin Exp Immunol       Date:  1994-08       Impact factor: 4.330

9.  Pathogenic serum IgG anticardiolipin antibodies and the idiotypic network.

Authors:  J Cohen; R Bakimer; M Blank; G Valesini; Y Shoenfeld
Journal:  Ann Rheum Dis       Date:  1993-10       Impact factor: 19.103

10.  MRL/lpr-->severe combined immunodeficiency mouse allografts produce autoantibodies, acute graft-versus-host disease or a wasting syndrome depending on the source of cells.

Authors:  D Ashany; J J Hines; A E Gharavi; J Mouradian; J Drappa; K B Elkon
Journal:  Clin Exp Immunol       Date:  1992-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.